Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryrfk jrbpc-157fdacompounding

Kennedy says administration wants regulated marketplace for peptides

His comments follow an FDA policy proposal sent to the White House last Thursday that could make it easier for pharmacies to compound certain peptides.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 20 18:01 ETSource: Yahoo

The wire

  1. 01Health Secretary Robert F. Kennedy Jr. told Fox News' "The Will Cain Show" the Trump administration aims to expand peptide access through a regulated market with inspected factories and verified contents.
  2. 02An FDA proposal under White House review could ease compounding of certain peptides, after outside advisers in July recommended loosening restrictions on six of seven peptides reviewed, including BPC-157, over FDA staff objections.
  3. 03The peptides in question are not FDA-approved as safe or effective, and Reuters notes human efficacy and safety evidence remains scant; no rule text or timeline has been published.

From the source

Kennedy says Trump administration aims for regulated market for peptides

WASHINGTON, Oct 20 (Reuters) - US Health Secretary Robert F. Kennedy Jr. said on Tuesday the Trump administration aims to expand access ‌to peptides by creating a regulated marketplace for the drugs promoted ‌by social media influencers and by the health secretary.

Read at yahoo.com
PeptiPrescribed peptides from $99/moSee all →